Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jessie R. Nedrow-Byers"'
Autor:
Clifford E. Berkman, Paul D. Benny, Jessie R. Nedrow-Byers, Melody D. Fulton, Adam L Moore, Tanushree Ganguly, Mark R. Hopkins
Publikováno v:
The Prostate. 73:355-362
The enzyme-biomarker prostate-specific membrane antigen (PSMA) is an active target for imaging and therapeutic applications for prostate cancer. The internalization of PSMA has been shown to vary with inhibitors' mode of binding: irreversible, slowly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb260f91b47f48ecd09f99fdf4f31a1d
https://doi.org/10.1002/pros.22575
https://doi.org/10.1002/pros.22575
Autor:
Paul D. Benny, Clifford E. Berkman, Mohamed Jabbes, Haiyang He, Tiancheng Liu, Cayla M. Jewett, Jessie R. Nedrow-Byers, Tanushree Ganguly, Jeffrey N. Bryan
Publikováno v:
The Prostate. 72:904-912
BACKGROUND Prostate-specific membrane antigen (PSMA) remains an active target for imaging and therapeutic applications for prostate cancer. METHODS In the present study, an irreversible phosphoramidate inhibitor, CTT-54 (IC50 = 14 nM), has been modif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a5e8575dd35abf8e25a78c2099083c1
https://doi.org/10.1002/pros.21493
https://doi.org/10.1002/pros.21493
Autor:
Benjamin B. Kasten, Paul D. Benny, Clifford E. Berkman, Jessie R. Nedrow-Byers, Tiancheng Liu
Prostate-specific membrane antigen (PSMA) is a notable biomarker for diagnostic and therapeutic applications in prostate cancer. Gold nanoparticles (AuNPs) provide an attractive nanomaterial platform for combining a variety of targeting, imaging, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa5b760e31e0f802eee9d8825ffbc2c
https://europepmc.org/articles/PMC3534887/
https://europepmc.org/articles/PMC3534887/
Autor:
Jessie R, Nedrow-Byers, Mohamed, Jabbes, Cayla, Jewett, Tanushree, Ganguly, Haiyang, He, Tiancheng, Liu, Paul, Benny, Jeffrey N, Bryan, Clifford E, Berkman
Publikováno v:
The Prostate. 72(8)
Prostate-specific membrane antigen (PSMA) remains an active target for imaging and therapeutic applications for prostate cancer.In the present study, an irreversible phosphoramidate inhibitor, CTT-54 (IC50 = 14 nM), has been modified to deliver 99mTc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e05f3d8532320752d25a98db582619e5
https://pubmed.ncbi.nlm.nih.gov/22670265
https://pubmed.ncbi.nlm.nih.gov/22670265
Publikováno v:
Bioorganicmedicinal chemistry letters. 21(23)
Prostate-specific membrane antigen (PSMA), a type II transmembrane protein, has been becoming an active target for imaging and therapeutic applications for prostate cancer. Recently, the development of its various chemical inhibitor scaffolds has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59d22e3da33e2e1b221a1259d55791ed
https://pubmed.ncbi.nlm.nih.gov/22018464
https://pubmed.ncbi.nlm.nih.gov/22018464
Autor:
Tiancheng Liu, Mohamed Jabbes, Clifford E. Berkman, Lisa Y. Wu, Jessie R. Nedrow-Byers, Jeffrey N. Bryan
Publikováno v:
International journal of oncology. 38(5)
Prostate-specific membrane antigen (PSMA), a well-known biomarker of prostate cancer, has also been found to be highly expressed in the neovasculature of multiple non-prostatic solid tumors. As a consequence, it has the potential to become a biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e88d488337c1b0e02c23bec2e04c2ae7
https://pubmed.ncbi.nlm.nih.gov/21331445
https://pubmed.ncbi.nlm.nih.gov/21331445
Autor:
Kaveh Vejdani, Henry F. VanBrocklin, Hilla Wahnishe, Suzanne E. Lapi, Lisa Y. Wu, Clifford E. Berkman, Jessie R. Nedrow-Byers, David M. Pham, Ella F. Jones, Tiancheng Liu
Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monitoring therapy. Although (111)In-labeled capropmab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba98e64065aca5845cfb6c665d62986
https://europepmc.org/articles/PMC3575752/
https://europepmc.org/articles/PMC3575752/
Autor:
Peter T. A. Reilly, Jeong Hoon Lee, Clifford E. Berkman, Jessie R. Nedrow-Byers, Lisa Y. Wu, Tiancheng Liu, Mark R. Hopkins
Publikováno v:
Molecular Cancer Therapeutics. 10:A117-A117
Introduction: Prostate-specific membrane antigen (PSMA), a type II membrane glycoprotein, has been confirmed to be an important tumor-marker indicating prostate cancer progression, and is becoming an active target for imaging or therapy for prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd4914ae88c7cb38927f38c8d1989c43
https://doi.org/10.1158/1535-7163.targ-11-a117
https://doi.org/10.1158/1535-7163.targ-11-a117